The company launched in November 2024 with $8 million in pre-seed funding. With its latest capital raise, Jimini's total funding now tops $25 million. Its patient-facing and patient-compliant AI platform, Sage, is a clinical-grade tool that operates within existing care pathways and the clinical context of a specific case and serves as a 24/7 behavioral health support chatbot for patients.

Jimini Health's seed round was led by investors at M13, Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind. The executives did not comment on any future growth plans or M&A activity that could be on the horizon.

Jimini's mission is to radically improve the efficacy of mental health care across the world. Jimini has developed Sage, the world's first AI behavioral health team member. Sage works as an always-available assistant alongside licensed providers, giving patients personalized support throughout their entire care journey. Sage benefits patients, providers, and organizations by enhancing outcomes, retention, and efficiency in ways previously unattainable.